Literature DB >> 11806991

Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release.

Gianfranco Mattia1, Francesca Vulcano, Luisa Milazzo, Alessandra Barca, Giampiero Macioce, Adele Giampaolo, H Jane Hassan.   

Abstract

Ploidy could be the key to understanding megakaryocyte (MK) biology and platelet production. Human CD34+ cells purified from umbilical cord blood (CB) and peripheral blood (PB) were investigated on their capability to give rise, in a serum-free medium containing thrombopoietin, to MKs and platelets. CB-MKs showed reduced polyploidization and platelet number compared with PB-MKs, but a similar membrane phenotype. Most CB-MKs showed a 2N content of DNA (approximately 80%) and only 2.6% had 8N, whereas 40% of the PB cells had 8N or more. Platelets were substantially released in PB culture from day 12; at day 14 the CB-derived MKs were able to release platelets although at a reduced level (approximately 35%), correlating with their reduced size. A direct correlation was demonstrated by sorting polyploid cells from PB-MKs and evaluating the platelets released in the supernatant. Furthermore, the study analyzed the expression and distribution of cyclin D3 and cyclin B1. Cyclin D3 protein was increased in PB in comparison to CB-MKs; in PB culture most cells rapidly became positive, whereas in CB-derived cells cyclin D3 expression was evident only from day 9 and in a reduced percentage. Cyclin B1 was essentially localized at the nuclear level in the CB and was expressed during the whole culture. In PB-MKs, at day 9, a reduction was observed, correlating with an advanced ploidy state. The data indicate the inability of the CB-MKs to progress in the endomitotic process and a direct correlation between DNA content and platelet production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11806991     DOI: 10.1182/blood.v99.3.888

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  77 in total

1.  Myosin-II repression favors pre/proplatelets but shear activation generates platelets and fails in macrothrombocytopenia.

Authors:  Kyle R Spinler; Jae-Won Shin; Michele P Lambert; Dennis E Discher
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

Review 2.  Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.

Authors:  Xiuli Sim; Mortimer Poncz; Paul Gadue; Deborah L French
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

3.  Nfe2 is dispensable for early but required for adult thrombocyte formation and function in zebrafish.

Authors:  Megan S Rost; Ilya Shestopalov; Yang Liu; Andy H Vo; Catherine E Richter; Sylvia M Emly; Francesca G Barrett; David L Stachura; Michael Holinstat; Leonard I Zon; Jordan A Shavit
Journal:  Blood Adv       Date:  2018-12-11

Review 4.  The effect of antiplatelet autoantibodies on megakaryocytopoiesis.

Authors:  Robert McMillan; Diane Nugent
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

Review 5.  In vivo platelet production from mature megakaryocytes: does platelet release occur via proplatelets?

Authors:  Goro Kosaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

6.  JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.

Authors:  Thomas Mercher; Gerlinde Wernig; Sandra A Moore; Ross L Levine; Ting-Lei Gu; Stefan Fröhling; Dana Cullen; Roberto D Polakiewicz; Olivier A Bernard; Titus J Boggon; Benjamin H Lee; D Gary Gilliland
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

Review 7.  Kinase signaling and targeted therapy for primary myelofibrosis.

Authors:  Qiong Yang; John D Crispino; Qiang Jeremy Wen
Journal:  Exp Hematol       Date:  2016-12-30       Impact factor: 3.084

8.  Tescalcin is an essential factor in megakaryocytic differentiation associated with Ets family gene expression.

Authors:  Konstantin Levay; Vladlen Z Slepak
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

9.  Megakaryocytes and platelets from a novel human adipose tissue-derived mesenchymal stem cell line.

Authors:  Keiichi Tozawa; Yukako Ono-Uruga; Masaki Yazawa; Taisuke Mori; Mitsuru Murata; Shinichiro Okamoto; Yasuo Ikeda; Yumiko Matsubara
Journal:  Blood       Date:  2018-11-28       Impact factor: 22.113

Review 10.  In vitro megakaryocyte production and platelet biogenesis: state of the art.

Authors:  Jo-Anna Reems; Nicolas Pineault; Sijie Sun
Journal:  Transfus Med Rev       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.